title: Greater risk sensitivity of dorsolateral prefrontal cortex in young smokers than in nonsmokers.
abstract: BACKGROUND
  Despite a national reduction in the prevalence of cigarette smoking, ~19% of the adult US population persists in this behavior, with the highest prevalence among 18-25-year-olds. Given that the choice to smoke imposes a known health risk, clarification of brain function related to decision-making, particularly involving risk-taking, in smokers may inform prevention and smoking cessation strategies.
  
  
  OBJECTIVE
  This study aimed to compare brain function related to decision-making in young smokers and nonsmokers.
  
  
  METHODS
  The Balloon Analogue Risk Task (BART) is a computerized risky decision-making task in which participants pump virtual balloons, each pump associated with an incremental increase in potential payoff on a given trial but also with greater risk of balloon explosion and loss of payoff. We used this task to compare brain activation associated with risky decision-making in smokers (n = 18) and nonsmokers (n = 25), while they performed the BART during functional magnetic resonance imaging (fMRI). The participants were young men and women, 17-21 years of age.
  
  
  RESULTS
  Risk level (number of pumps) modulated brain activation in the right dorsolateral and ventrolateral prefrontal cortices more in smokers than in nonsmokers, and smoking severity (Heaviness of Smoking Index) was positively related to this modulation in an adjacent frontal region.
  
  
  CONCLUSIONS
  Given evidence for involvement of the right dorsolateral and ventrolateral prefrontal cortices in inhibitory control, these findings suggest that young smokers have a different contribution of prefrontal cortical substrates to risky decision-making than nonsmokers. Future studies are warranted to determine whether the observed neurobiological differences precede or result from smoking.
authors: Department of Psychology, University of California, Los Angeles, Los Angeles, CA, USA.
authors: Adriana
authors: A
authors: Galván
authors: Tom
authors: T
authors: Schonberg
authors: Jeanette
authors: J
authors: Mumford
authors: Milky
authors: M
authors: Kohno
authors: Russell A
authors: RA
authors: Poldrack
authors: Edythe D
authors: ED
authors: London
mesh_terms: D000293:Adolescent; D003657:Decision Making / Q000502:physiology*; D005260:Female; D006801:Humans; D007091:Image Processing, Computer-Assisted; D016014:Linear Models; D008279:Magnetic Resonance Imaging; D008297:Male; D017397:Prefrontal Cortex / Q000503:physiopathology*; D012309:Risk-Taking; D012907:Smoking / Q000473:pathology* / Q000523:psychology*; D055815:Young Adult
references: Alcohol Clin Exp Res. 2012 Jun;36(6):932-40
references: 22309791
references: Pharmacol Biochem Behav. 2000 Jul;66(3):553-8
references: 10899369
references: Handb Exp Pharmacol. 2009;(192):113-43
references: 19184648
references: Neuroimage. 2008 Jun;41(2):286-301
references: 18407525
references: Arch Gen Psychiatry. 1986 Mar;43(3):289-94
references: 3954551
references: Magn Reson Imaging. 2001 Oct;19(8):1055-62
references: 11711229
references: J Exp Psychol Hum Percept Perform. 2012 Apr;38(2):290-301
references: 22201469
references: Hum Brain Mapp. 1999;8(2-3):102-8
references: 10524600
references: J Adolesc. 2003 Aug;26(4):475-9
references: 12887935
references: Neuropsychopharmacology. 2011 Apr;36(5):970-8
references: 21270772
references: Cogn Affect Behav Neurosci. 2012 Sep;12(3):479-90
references: 22707378
references: Stroke. 1983 Sep-Oct;14(5):720-4
references: 6658956
references: Neuropsychopharmacology. 2007 Jun;32(6):1421-8
references: 17164821
references: Nat Neurosci. 2008 Apr;11(4):514-20
references: 18311134
references: Addiction. 1998 Mar;93(3):317-20
references: 10328040
references: Drug Alcohol Depend. 2012 Apr 1;122(1-2):112-8
references: 21992873
references: Neuroimage. 2008 Aug 15;42(2):902-10
references: 18582578
references: Psychopharmacology (Berl). 2007 Sep;193(4):557-66
references: 17505817
references: Nicotine Tob Res. 1999;1 Suppl 2:S143-7; discussion S165-6
references: 11768172
references: J Neurosci. 2007 Nov 14;27(46):12500-5
references: 18003828
references: Nicotine Tob Res. 2005 Feb;7(1):71-9
references: 15804679
references: Psychopharmacology (Berl). 2011 Jun;215(4):801-11
references: 21293849
references: Exp Clin Psychopharmacol. 2003 Feb;11(1):26-33
references: 12622341
references: Biomed Pharmacother. 2004 Mar;58(2):77-83
references: 14992787
references: J Exp Psychol Appl. 2002 Jun;8(2):75-84
references: 12075692
references: Psychopharmacology (Berl). 2009 Dec;207(3):343-63
references: 19830407
references: Psychopharmacology (Berl). 2012 Jan;219(2):563-73
references: 21766170
references: Psychol Sci Public Interest. 2006 Sep;7(1):1-44
references: 26158695
references: MMWR Morb Mortal Wkly Rep. 2007 Nov 9;56(44):1157-61
references: 17989644
references: Exp Clin Psychopharmacol. 2009 Oct;17(5):302-11
references: 19803629
references: Biol Psychiatry. 2011 Oct 15;70(8):794-799
references: 21762878
references: J Cogn Neurosci. 2013 Mar;25(3):374-87
references: 23163412
references: Front Neurosci. 2012 Jun 04;6:80
references: 22675289
references: Neuroimage. 2002 Oct;17(2):825-41
references: 12377157
references: Nicotine Tob Res. 2010 Oct;12 Suppl:S45-50
references: 20889480
references: Neuropsychopharmacology. 2010 Jul;35(8):1797-806
references: 20375994
references: Pharmacol Biochem Behav. 2009 Sep;93(3):258-62
references: 19041886
references: Neuroimage. 2003 Oct;20(2):1052-63
references: 14568475
references: Exp Clin Psychopharmacol. 2008 Apr;16(2):113-23
references: 18489015
references: Addict Behav. 2006 May;31(5):833-44
references: 16009504
references: MMWR Morb Mortal Wkly Rep. 2011 Sep 9;60(35):1207-12
references: 21900875
references: Neuropsychopharmacology. 2007 Dec;32(12):2453-64
references: 17375135
references: Biol Psychiatry. 2005 Jul 15;58(2):143-50
references: 16038685
references: Neuroimage. 1997 Feb;5(2):83-96
references: 9345540